Literature DB >> 21716006

FDG PET/CT in evaluation of pyrexia of unknown origin.

Shrikant Vasantrao Solav1.   

Abstract

Pyrexia of unknown origin (PUO) is defined as fever above 38.5°C lasting for 3 weeks, of which at least 1 week has been spent in thorough investigation without a conclusive cause. Tuberculosis remains an important cause of PUO, particularly with the rising incidence of human immunodeficiency virus infection. It may strike virtually any organ in the body and can even mimic metastases especially in a known treated case of carcinoma. Bacterial infections, human immunodeficiency virus, hidden malignancy, sarcoidosis, and autoimmune disorders are some other important causes of PUO. Initial investigations include examination of blood, urine, stool, blood biochemistry, culture, etc. Typical radiologic investigations include chest radiography, computed tomography, and magnetic resonance imaging. Presented here is an atlas of cases where these investigations had been inconclusive but fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography demonstrated the site of pathology and directed histologic diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716006     DOI: 10.1097/RLU.0b013e31821c99b2

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.

Authors:  Eun Ji Han; Yi Sun Jang; In Suk Lee; Jong Min Lee; Siwon Kang; Hye Soo Kim
Journal:  J Korean Med Sci       Date:  2013-08-28       Impact factor: 2.153

2.  Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still's disease.

Authors:  Liyan Wan; Yuting Gao; Jieyu Gu; Huihui Chi; Zhihong Wang; Qiongyi Hu; Jinchao Jia; Tingting Liu; Biao Li; Jialin Teng; Honglei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Chengde Yang; Hui Shi; Min Zhang
Journal:  Arthritis Res Ther       Date:  2021-03-30       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.